Kľoc, D.; Dubiková, B.; Žiláková, S.; Sykora, J.; Šuliková, M.; Kurhajec, S.; Sabo, J.; Guman, T.; Šarišský, M.
The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines. Molecules 2026, 31, 531.
https://doi.org/10.3390/molecules31030531
AMA Style
Kľoc D, Dubiková B, Žiláková S, Sykora J, Šuliková M, Kurhajec S, Sabo J, Guman T, Šarišský M.
The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines. Molecules. 2026; 31(3):531.
https://doi.org/10.3390/molecules31030531
Chicago/Turabian Style
Kľoc, Dominik, Bianca Dubiková, Simona Žiláková, Ján Sykora, Michaela Å uliková, SlavomÃr Kurhajec, Ján Sabo, Tomáš Guman, and Marek Å ariÅ¡ský.
2026. "The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines" Molecules 31, no. 3: 531.
https://doi.org/10.3390/molecules31030531
APA Style
Kľoc, D., Dubiková, B., Žiláková, S., Sykora, J., Šuliková, M., Kurhajec, S., Sabo, J., Guman, T., & Šarišský, M.
(2026). The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines. Molecules, 31(3), 531.
https://doi.org/10.3390/molecules31030531